Skip to content

Application of esketamine-mediated opioid-free anesthesia in laparoscopic cholecystectomy under multimodal analgesia

Application of esketamine-mediated opioid-free anesthesia in laparoscopic cholecystectomy under multimodal analgesia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064236
Enrollment
Unknown
Registered
2022-10-01
Start date
2022-10-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallstones, cholecystitis

Interventions

Group OFA:opioid-free anaesthesia based on multimodal analgesia
Group OSA:opioid-sparing anesthesia based on multimodal analgesia

Sponsors

Affiliated Hospital of Jiangnan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. In line with the indications for cholecystectomy, including cholecystolithiasis, cholecystitis, elective surgery; 2. The American Society of Anesthesiologists (ASA) classification is grade I~II, the patient is in good physical condition, the organ function is normal or the compensation is sound, and the operation can be tolerated; 3. Aged 18~65 years, body mass index (BMI) 18 kg/m2~32kg/m2; 4. No opioids were taken 48 hours before surgery; 5. Not taking non-steroidal antipyretic, analgesic and anti-inflammatory drugs 48 hours before surgery; 6. Able to communicate normally, without language, hearing or cognitive impairment.

Exclusion criteria

Exclusion criteria: 1. Severe heart, brain, lung, endocrine, malignant tumor diseases; 2. Liver and kidney insufficiency; 3. Abnormal coagulation function; 4. Unwilling to accept TAP block or infection at the abdominal wall puncture site; 5. History of allergy to anesthetics; 6. History of alcoholism, drug addiction, addiction to opioids and tranquilizers; 7. Long-term use of antipsychotic drugs; 8. Contraindications to surgery, or inability to tolerate surgery; 9. Gallbladder cancer, gallbladder sarcoma, obstructive jaundice of unknown etiology; 10. Recent use of drugs that affect the sympathetic-adrenergic system.

Design outcomes

Primary

MeasureTime frame
hemodynamic changes;

Secondary

MeasureTime frame
NRS pain score;Ramsay sedation score;Adverse reactions;cortisol;

Countries

China

Contacts

Public ContactZhongjun Zhang

Affiliated Hospital of Jiangnan University

zzj315@vip.sina.com+86 13961802567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026